Results 261 to 270 of about 484,364 (380)

Pathological Disulfide Bond Crosslinking: Molecular Insights into Amyloidogenesis and Diseases Progression

open access: yesChemBioChem, EarlyView.
This review explores pathological disulfide‐crosslinking as a key driver of amyloidogenic protein misfolding and aggregation. Oxidative and ER stress pathways contributing to disease progression are discussed and emerging therapeutic strategies targeting disulfide‐linked aggregates in neurodegenerative and systemic amyloid diseases are examined ...
Dong Min Kang   +4 more
wiley   +1 more source

Hijacking the Electron Train: Menaquinone‐Binding Antimicrobial Peptides

open access: yesChemBioChem, EarlyView.
Menaquinone is an emerging target for antimicrobial peptides. Could it be the new Achilles’ Heel of bacteria? The rise of antibiotic resistance threatens to undermine modern medicine, making the development of new antibiotics and novel targets an urgent priority.
Eilidh J. Matheson, Stephen A. Cochrane
wiley   +1 more source

Solid Medication Intake in Hospitalised Patients With Dysphagia: A Challenge for Speech and Language Pathologists? [PDF]

open access: yesInt J Lang Commun Disord
Trapl-Grundschober M   +6 more
europepmc   +1 more source

Breaking the Barrier: Unraveling the No‐Reflow Phenomenon in Cardiovascular Medicine

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The no‐reflow phenomenon is a stubborn and often devastating complication in cardiovascular medicine, where blood flow is restored to an artery, yet the microvasculature remains unresponsive. First identified in 1967, this phenomenon has haunted clinicians and researchers alike, particularly in the context of acute myocardial infarction (AMI).
Stephanie Howes   +9 more
wiley   +1 more source

Medication Administration in Poststroke Dysphagia: Evaluating Swallowing Safety of Solid Dosage Forms. [PDF]

open access: yesStroke
Trapl-Grundschober M   +5 more
europepmc   +1 more source

Navigating the Uncertainties of Antithrombotic Therapy After Transcatheter Patent Foramen Ovale Closure: A Comprehensive Review

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The patent foramen ovale (PFO), present in 25% of the population, can cause paradoxical embolism and stroke. Transcatheter PFO closure is the gold standard for recurrent embolism with significant inter‐atrial shunting, with recent trials confirming its superiority in reducing ischemic stroke recurrence over medical therapy.
Eirini Beneki   +13 more
wiley   +1 more source

How do placebos work?

open access: yesEuropean Journal of Psychotraumatology, 2018
Fabrizio Benedetti   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy